Anzahl der Einträge: 3.
Schwab, Melissa,
Thunborg, Katharina,
Azimzadeh, Omid ![ORCID 0000-0001-8984-0388](/images/orcid_16x16.gif)
,
von Toerne, Christine,
Werner, Caroline,
Shevtsov, Maxim ![ORCID 0000-0002-8539-2239](/images/orcid_16x16.gif)
,
Di Genio, Tommaso,
Zdralevic, Masa,
Pouyssegur, Jacques ![ORCID 0000-0003-2779-6902](/images/orcid_16x16.gif)
,
Renner, Kathrin,
Kreutz, Marina und
Multhoff, Gabriele ![ORCID 0000-0002-2616-3137](/images/orcid_16x16.gif)
(2021)
Targeting Cancer Metabolism Breaks Radioresistance by Impairing the Stress Response.
Cancers 13 (15), S. 3762.
Volltext nicht vorhanden.
Multhoff, Gabriele,
Seier, Sophie,
Stangl, Stefan,
Sievert, Wolfgang,
Shevtsov, Maxim ![ORCID 0000-0002-8539-2239](/images/orcid_16x16.gif)
,
Werner, Caroline,
Pockley, A. Graham ![ORCID 0000-0001-9593-6431](/images/orcid_16x16.gif)
,
Blankenstein, Christiane,
Hildebrandt, Martin,
Offner, Robert,
Ahrens, Norbert,
Kokowski, Konrad,
Hautmann, Matthias,
Rödel, Claus,
Fietkau, Rainer,
Lubgan, Dorota,
Huber, Rudolf ![ORCID 0000-0001-7041-6368](/images/orcid_16x16.gif)
,
Hautmann, Hubert,
Duell, Thomas,
Molls, Michael,
Specht, Hanno,
Haller, Bernhard,
Devecka, Michal,
Sauter, Andreas und
Combs, Stephanie E.
(2020)
Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial.
Clinical Cancer Research 26 (20), S. 5368-5379.
Volltext nicht vorhanden.
Multhoff, Gabriele,
Combs, Stephanie E.,
Seier, Sophie,
Stangl, Stefan,
Sievert, Wolfgang,
Shevtsov, Maxim ![ORCID 0000-0002-8539-2239](/images/orcid_16x16.gif)
,
Blankenstein, Christiane,
Hildebrandt, Martin,
Kokowski, Konrad,
Hautmann, Matthias,
Hautmann, Hubert,
Rödel, Claus,
Fietkau, Rainer,
Huber, Rudolf ![ORCID 0000-0001-7041-6368](/images/orcid_16x16.gif)
,
Haller, Bernhard,
Ertl, Christine,
Devecka, Michal,
Offner, Robert ![ORCID 0000-0003-0160-8248](/images/orcid_16x16.gif)
und
Ahrens, Norbert ![ORCID 0000-0002-4680-2688](/images/orcid_16x16.gif)
(2020)
Abstract LB-076: Targeted Natural Killer (NK) cell based adoptive immunotherapy for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy - results of a randomized phase II clinical trial (NSCLC-TKD/IL-2) (Eudra-CT Number 2008-002130-30).
Cancer research 80 (16supp).
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Wed Jul 17 20:56:22 2024 CEST.